Table 3.
Hippocampal subfields | IL-1β | IL-6 | IFN-γ | TNF-α | Effects of diagnosis (MDD vs. control) | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
B | SE | p | B | SE | p | B | SE | p | B | SE | p | B | SE | p | |
Left | |||||||||||||||
CA1 | −0.108 | 0.164 | 0.515 | −0.32 | 0.167 | 0.064 | 0.097 | 0.164 | 0.56 | 0.119 | 0.183 | 0.518 | <0.001 | 0.115 | 0.998 |
CA3 | −0.128 | 0.167 | 0.45 | −0.244 | 0.172 | 0.164 | 0.088 | 0.166 | 0.598 | −0.08 | 0.185 | 0.67 | −0.013 | 0.116 | 0.911 |
CA4 | −0.071 | 0.161 | 0.66 | −0.262 | 0.164 | 0.119 | 0.082 | 0.159 | 0.609 | 0.04 | 0.178 | 0.823 | −0.009 | 0.115 | 0.941 |
GC-DG | −0.079 | 0.156 | 0.618 | −0.268 | 0.159 | 0.1 | 0.086 | 0.155 | 0.581 | 0.064 | 0.173 | 0.713 | −0.071 | 0.113 | 0.535 |
fimbria | 0.087 | 0.145 | 0.556 | 0.169 | 0.149 | 0.262 | 0.221 | 0.137 | 0.116 | 0.139 | 0.157 | 0.381 | −0.163 | 0.105 | 0.125 |
subiculum | 0.171 | 0.159 | 0.291 | −0.339 | 0.161 | 0.042* | 0.11 | 0.159 | 0.494 | 0.189 | 0.176 | 0.292 | −0.038 | 0.112 | 0.734 |
presubiculum | 0.066 | 0.162 | 0.687 | −0.106 | 0.167 | 0.529 | −0.191 | 0.155 | 0.225 | 0.167 | 0.175 | 0.346 | −0.178 | 0.113 | 0.118 |
parasubiculum | 0.154 | 0.171 | 0.376 | −0.038 | 0.181 | 0.833 | −0.294 | 0.163 | 0.08 | 0.052 | 0.19 | 0.788 | −0.116 | 0.115 | 0.319 |
molecular layer | <0.001 | 0.156 | 0.998 | −0.253 | 0.16 | 0.122 | 0.015 | 0.156 | 0.923 | 0.102 | 0.173 | 0.562 | −0.054 | 0.113 | 0.635 |
HATA | −0.062 | 0.167 | 0.714 | 0.033 | 0.174 | 0.852 | −0.011 | 0.163 | 0.947 | −0.212 | 0.179 | 0.244 | −0.2 | 0.112 | 0.079 |
hippocampal tail | 0.011 | 0.157 | 0.947 | −0.186 | 0.161 | 0.254 | −0.041 | 0.154 | 0.789 | 0.109 | 0.171 | 0.528 | 0.029 | 0.11 | 0.794 |
whole hippocampus | 0.006 | 0.153 | 0.97 | −0.288 | 0.155 | 0.071 | 0.03 | 0.152 | 0.843 | 0.136 | 0.169 | 0.426 | −0.059 | 0.113 | 0.599 |
Right | |||||||||||||||
CA1 | −0.026 | 0.162 | 0.871 | −0.347 | 0.162 | 0.039* | 0.098 | 0.161 | 0.549 | 0.054 | 0.181 | 0.765 | 0.058 | 0.114 | 0.612 |
CA3 | −0.081 | 0.159 | 0.613 | −0.329 | 0.158 | 0.045* | −0.032 | 0.157 | 0.841 | −0.127 | 0.174 | 0.471 | 0.139 | 0.113 | 0.223 |
CA4 | 0.057 | 0.156 | 0.717 | −0.323 | 0.156 | 0.046* | 0.006 | 0.155 | 0.968 | −0.046 | 0.173 | 0.793 | 0.042 | 0.114 | 0.712 |
GC-DG | 0.051 | 0.154 | 0.744 | −0.355 | 0.152 | 0.025* | 0.012 | 0.153 | 0.94 | −0.036 | 0.171 | 0.832 | −0.008 | 0.113 | 0.943 |
fimbria | −0.031 | 0.155 | 0.842 | 0.149 | 0.158 | 0.35 | 0.073 | 0.15 | 0.627 | −0.134 | 0.166 | 0.425 | −0.114 | 0.103 | 0.272 |
subiculum | 0.11 | 0.171 | 0.525 | −0.261 | 0.175 | 0.144 | −0.056 | 0.169 | 0.741 | 0.152 | 0.187 | 0.422 | −0.048 | 0.115 | 0.674 |
presubiculum | 0.106 | 0.167 | 0.53 | −0.034 | 0.175 | 0.849 | −0.289 | 0.157 | 0.075 | 0.074 | 0.184 | 0.69 | −0.174 | 0.113 | 0.129 |
parasubiculum | 0.073 | 0.166 | 0.664 | 0.073 | 0.175 | 0.677 | 0.072 | 0.164 | 0.663 | −0.072 | 0.184 | 0.699 | −0.025 | 0.115 | 0.826 |
molecular layer | 0.022 | 0.161 | 0.891 | −0.297 | 0.162 | 0.075 | −0.012 | 0.159 | 0.942 | 0.024 | 0.178 | 0.893 | −0.019 | 0.113 | 0.87 |
HATA | −0.006 | 0.156 | 0.968 | −0.092 | 0.166 | 0.583 | 0.178 | 0.153 | 0.253 | −0.116 | 0.174 | 0.509 | −0.072 | 0.114 | 0.526 |
hippocampal tail | 0.097 | 0.154 | 0.534 | −0.332 | 0.152 | 0.036* | −0.031 | 0.152 | 0.84 | 0.142 | 0.169 | 0.407 | −0.12 | 0.104 | 0.252 |
whole hippocampus | 0.051 | 0.156 | 0.746 | −0.326 | 0.155 | 0.043* | −0.017 | 0.155 | 0.912 | 0.045 | 0.173 | 0.797 | −0.042 | 0.111 | 0.705 |
B (SE) 5 b value (standard error of the mean). MDD = Major depression disorders, IL = Interleukin, IFN = interferon, TNF = Tumor necrosis factor. CA = cornu ammonis, GC-DG = granule cell layer of dentate gyrus, HATA = hippocampus-amygdala-transition-area, hippocampal tail, and whole hippocampus. Age, sex, and intracranial volume are entered as covariates in analyses. *Significant correlation between the hippocampal subfield volumes and serum cytokine levels in MDD patients are detected (p < 0.05).